Presentation is loading. Please wait.

Presentation is loading. Please wait.

ORAL SESSIONS Journal of Thoracic Oncology

Similar presentations


Presentation on theme: "ORAL SESSIONS Journal of Thoracic Oncology"— Presentation transcript:

1 ORAL SESSIONS Journal of Thoracic Oncology
Journal of Thoracic Oncology  Volume 10, Issue 9, Pages S173-S260 (September 2015) DOI: /S (16) Copyright © 2015 International Association for the Study of Lung Cancer Terms and Conditions

2 Journal of Thoracic Oncology 2015 10, S173-S260DOI: (10
Journal of Thoracic Oncology  , S173-S260DOI: ( /S (16) ) Copyright © 2015 International Association for the Study of Lung Cancer Terms and Conditions

3 Journal of Thoracic Oncology 2015 10, S173-S260DOI: (10
Journal of Thoracic Oncology  , S173-S260DOI: ( /S (16) ) Copyright © 2015 International Association for the Study of Lung Cancer Terms and Conditions

4 Figure 1 Frequency of genomic alterations identified in this study
Journal of Thoracic Oncology  , S173-S260DOI: ( /S (16) ) Copyright © 2015 International Association for the Study of Lung Cancer Terms and Conditions

5 Journal of Thoracic Oncology 2015 10, S173-S260DOI: (10
Journal of Thoracic Oncology  , S173-S260DOI: ( /S (16) ) Copyright © 2015 International Association for the Study of Lung Cancer Terms and Conditions

6 Journal of Thoracic Oncology 2015 10, S173-S260DOI: (10
Journal of Thoracic Oncology  , S173-S260DOI: ( /S (16) ) Copyright © 2015 International Association for the Study of Lung Cancer Terms and Conditions

7 Journal of Thoracic Oncology 2015 10, S173-S260DOI: (10
Journal of Thoracic Oncology  , S173-S260DOI: ( /S (16) ) Copyright © 2015 International Association for the Study of Lung Cancer Terms and Conditions

8 Journal of Thoracic Oncology 2015 10, S173-S260DOI: (10
Journal of Thoracic Oncology  , S173-S260DOI: ( /S (16) ) Copyright © 2015 International Association for the Study of Lung Cancer Terms and Conditions

9 Journal of Thoracic Oncology 2015 10, S173-S260DOI: (10
Journal of Thoracic Oncology  , S173-S260DOI: ( /S (16) ) Copyright © 2015 International Association for the Study of Lung Cancer Terms and Conditions

10 Figure 1 Examples of 3D T 1-weighted Pleural MR images acquired 4.5 minutes post-Gadobutrol in 2 different patients – one with BAPE (Panel A) and one with early-stage MPM (Panel B). Panels C and D show the accompanying parietal pleura SI/time curves for each patient (Panel C: patient with BAPE – ECE absent, Panel D: patient with MPM – ECE present) Journal of Thoracic Oncology  , S173-S260DOI: ( /S (16) ) Copyright © 2015 International Association for the Study of Lung Cancer Terms and Conditions

11 Figure 1 A) Serum cisplatin kinetics over 120 hours and B) Cumulative and pre-dose subtracted AUC0-120 of the 4 dose levels, Data is presented in median with range (n=3 for each dosage group). Journal of Thoracic Oncology  , S173-S260DOI: ( /S (16) ) Copyright © 2015 International Association for the Study of Lung Cancer Terms and Conditions

12 Journal of Thoracic Oncology 2015 10, S173-S260DOI: (10
Journal of Thoracic Oncology  , S173-S260DOI: ( /S (16) ) Copyright © 2015 International Association for the Study of Lung Cancer Terms and Conditions

13 Journal of Thoracic Oncology 2015 10, S173-S260DOI: (10
Journal of Thoracic Oncology  , S173-S260DOI: ( /S (16) ) Copyright © 2015 International Association for the Study of Lung Cancer Terms and Conditions

14 Journal of Thoracic Oncology 2015 10, S173-S260DOI: (10
Journal of Thoracic Oncology  , S173-S260DOI: ( /S (16) ) Copyright © 2015 International Association for the Study of Lung Cancer Terms and Conditions

15 Journal of Thoracic Oncology 2015 10, S173-S260DOI: (10
Journal of Thoracic Oncology  , S173-S260DOI: ( /S (16) ) Copyright © 2015 International Association for the Study of Lung Cancer Terms and Conditions

16 Journal of Thoracic Oncology 2015 10, S173-S260DOI: (10
Journal of Thoracic Oncology  , S173-S260DOI: ( /S (16) ) Copyright © 2015 International Association for the Study of Lung Cancer Terms and Conditions

17 Journal of Thoracic Oncology 2015 10, S173-S260DOI: (10
Journal of Thoracic Oncology  , S173-S260DOI: ( /S (16) ) Copyright © 2015 International Association for the Study of Lung Cancer Terms and Conditions

18 Journal of Thoracic Oncology 2015 10, S173-S260DOI: (10
Journal of Thoracic Oncology  , S173-S260DOI: ( /S (16) ) Copyright © 2015 International Association for the Study of Lung Cancer Terms and Conditions

19 Journal of Thoracic Oncology 2015 10, S173-S260DOI: (10
Journal of Thoracic Oncology  , S173-S260DOI: ( /S (16) ) Copyright © 2015 International Association for the Study of Lung Cancer Terms and Conditions

20 Journal of Thoracic Oncology 2015 10, S173-S260DOI: (10
Journal of Thoracic Oncology  , S173-S260DOI: ( /S (16) ) Copyright © 2015 International Association for the Study of Lung Cancer Terms and Conditions

21 Journal of Thoracic Oncology 2015 10, S173-S260DOI: (10
Journal of Thoracic Oncology  , S173-S260DOI: ( /S (16) ) Copyright © 2015 International Association for the Study of Lung Cancer Terms and Conditions

22 Journal of Thoracic Oncology 2015 10, S173-S260DOI: (10
Journal of Thoracic Oncology  , S173-S260DOI: ( /S (16) ) Copyright © 2015 International Association for the Study of Lung Cancer Terms and Conditions

23 Journal of Thoracic Oncology 2015 10, S173-S260DOI: (10
Journal of Thoracic Oncology  , S173-S260DOI: ( /S (16) ) Copyright © 2015 International Association for the Study of Lung Cancer Terms and Conditions

24 Journal of Thoracic Oncology 2015 10, S173-S260DOI: (10
Journal of Thoracic Oncology  , S173-S260DOI: ( /S (16) ) Copyright © 2015 International Association for the Study of Lung Cancer Terms and Conditions

25 Journal of Thoracic Oncology 2015 10, S173-S260DOI: (10
Journal of Thoracic Oncology  , S173-S260DOI: ( /S (16) ) Copyright © 2015 International Association for the Study of Lung Cancer Terms and Conditions

26 Journal of Thoracic Oncology 2015 10, S173-S260DOI: (10
Journal of Thoracic Oncology  , S173-S260DOI: ( /S (16) ) Copyright © 2015 International Association for the Study of Lung Cancer Terms and Conditions

27 Journal of Thoracic Oncology 2015 10, S173-S260DOI: (10
Journal of Thoracic Oncology  , S173-S260DOI: ( /S (16) ) Copyright © 2015 International Association for the Study of Lung Cancer Terms and Conditions

28 Journal of Thoracic Oncology 2015 10, S173-S260DOI: (10
Journal of Thoracic Oncology  , S173-S260DOI: ( /S (16) ) Copyright © 2015 International Association for the Study of Lung Cancer Terms and Conditions

29 Journal of Thoracic Oncology 2015 10, S173-S260DOI: (10
Journal of Thoracic Oncology  , S173-S260DOI: ( /S (16) ) Copyright © 2015 International Association for the Study of Lung Cancer Terms and Conditions

30 Figure 1 Survival by Surgeon Score
Journal of Thoracic Oncology  , S173-S260DOI: ( /S (16) ) Copyright © 2015 International Association for the Study of Lung Cancer Terms and Conditions

31 Journal of Thoracic Oncology 2015 10, S173-S260DOI: (10
Journal of Thoracic Oncology  , S173-S260DOI: ( /S (16) ) Copyright © 2015 International Association for the Study of Lung Cancer Terms and Conditions

32 Journal of Thoracic Oncology 2015 10, S173-S260DOI: (10
Journal of Thoracic Oncology  , S173-S260DOI: ( /S (16) ) Copyright © 2015 International Association for the Study of Lung Cancer Terms and Conditions

33 Journal of Thoracic Oncology 2015 10, S173-S260DOI: (10
Journal of Thoracic Oncology  , S173-S260DOI: ( /S (16) ) Copyright © 2015 International Association for the Study of Lung Cancer Terms and Conditions

34 Figure 1 Examples of lung cancer specimens with concordance of scores by seven pathologists for faint (A), moderate (B) and strong (C) expression of cMET protein by immunohistochemistry (all pictures taken with 40X objective) Journal of Thoracic Oncology  , S173-S260DOI: ( /S (16) ) Copyright © 2015 International Association for the Study of Lung Cancer Terms and Conditions

35 Journal of Thoracic Oncology 2015 10, S173-S260DOI: (10
Journal of Thoracic Oncology  , S173-S260DOI: ( /S (16) ) Copyright © 2015 International Association for the Study of Lung Cancer Terms and Conditions

36 Journal of Thoracic Oncology 2015 10, S173-S260DOI: (10
Journal of Thoracic Oncology  , S173-S260DOI: ( /S (16) ) Copyright © 2015 International Association for the Study of Lung Cancer Terms and Conditions

37 Journal of Thoracic Oncology 2015 10, S173-S260DOI: (10
Journal of Thoracic Oncology  , S173-S260DOI: ( /S (16) ) Copyright © 2015 International Association for the Study of Lung Cancer Terms and Conditions

38 Journal of Thoracic Oncology 2015 10, S173-S260DOI: (10
Journal of Thoracic Oncology  , S173-S260DOI: ( /S (16) ) Copyright © 2015 International Association for the Study of Lung Cancer Terms and Conditions

39 Fig 1 Low SMARCA4 correlates with improved disease-specific survival with adjuvant cisplatin-based chemotherapy in the JBR.10 trial. Journal of Thoracic Oncology  , S173-S260DOI: ( /S (16) ) Copyright © 2015 International Association for the Study of Lung Cancer Terms and Conditions


Download ppt "ORAL SESSIONS Journal of Thoracic Oncology"

Similar presentations


Ads by Google